Shares of Puma Biotechnology (NASDAQ:PBYI) rose 0.32 in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share increased 136.08% year over year to $0.35, which beat the estimate of ($0.30).

Revenue of $70,600,000 higher by 30.98% from the same period last year, which beat the estimate of $58,210,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

Puma Biotechnology hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Aug 06, 2020

Time: 04:30 PM

ET Webcast URL: https://78449.themediaframe.com/dataconf/productusers/pbyi/mediaframe/39132/indexl.html

Technicals

52-week high: $15.00

Company's 52-week low was at $5.50

Price action over last quarter: down 9.91%

Company Overview